$103.67
1.201.17%
Last update: Nov 2, 4:00 PM
HealthEquity Inc
HQYNASDAQ
HealthEquity (HQY) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
HealthEquity (HQY) last issued guidance on August 27, 2026 for fiscal year 2027. The company guided earnings per share in the range of $4.66 - $4.73, compared to a consensus EPS estimate of $4.56. HealthEquity also guided revenue in the range of $1.41B - $1.42B for the period.
Compared to prior guidance, HealthEquity maintained its EPS outlook from a previous range of $4.66 - $4.73. On the revenue side, the company maintained its revenue forecast from a prior range of $1.41B - $1.42B.
HealthEquity has issued 24 guidance updates between December 6, 2022 and August 27, 2026. During this period, the company raised its outlook 16 times, reflecting management's growing confidence in business performance.
| Metric | Q2 '27 | Q1 '27 | Q4 '26 | Q3 '26 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $1.15 | $1.08 | $0.82 | $0.83 |
| Actual | $1.24 | $1.24 | $0.95 | $1.01 |
| Surprise | +7.83% | +14.8% | +15.8% | +21.7% |
| Revenue | ||||
| Estimate | $349.4M | $352.6M | $332.8M | $320.6M |
| Actual | $350.7M | $354.6M | $334.6M | $322.2M |
| Surprise | +0.37% | +0.57% | -99.9% | +0.50% |
| Metric | Q3 '27E | Q4 '27E | Q1 '28E | Q2 '28E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $1.11 | $1.06 | $1.24 | $1.21 |
| Revenue | ||||
| Consensus | $347.3M | $364.2M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 27, 2026 | $1.24 | $1.15 | 7.83 % |
| Q1 | May 28, 2026 | $1.24 | $1.08 | 14.8 % |
| Q4 | Mar 17, 2026 | $0.95 | $0.82 | 15.8 % |
| Q3 | Dec 3, 2025 | $1.01 | $0.83 | 21.7 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 27, 2026 | $350.73M | $349.43M | 0.37 % |
| Q1 | May 28, 2026 | $354.64M | $352.62M | 0.57 % |
| Q4 | Mar 17, 2026 | $334.59M | $332.83M | -99.9 % |
| Q3 | Dec 3, 2025 | $322.16M | $320.56M | 0.50 % |
